Development of a novel albumin-based and maleimidopropionic acid-conjugated peptide with prolonged half-life and increased in vivo anti-tumor efficacy

Conclusions: Taken together, our results demonstrated that F56-CM has considerable potential for cancer therapy.

Source: Theranostics - June 20, 2018 Category: Molecular Biology Authors: Junnan Feng, Chuanke Zhao, Lixin Wang, Like Qu, Hua Zhu, Zhi Yang, Guo An, Huifang Tian, Chengchao Shou Tags: Research Paper Source Type: research